DR, glaucoma and AMD screening in 10 seconds - offline, right on your Remidio FOP NM-10
One tap, 3 results, 10 seconds
With a single tap, run MediosHI AI on captured fundus images to effortlessly screen patients at risk of referable DR, AMD & referral warranted glaucoma.
The only offline AI that runs anywhere, anytime
MediosHI AI can analyse & generate results without depending on an internet connection – perfect solution for your outreach screenings & in-clinic usage.
Expert grade results with high accuracy
Only AI to be prospectively validated across 20+ clinical sites demonstrating high clinical specificity & sensitivity.
Performance of MediosHI Retinal Assessment Software
Sensitivity
Specificity
Medios DR AI*
93.0%
92.5%
MediosHI Glaucoma**
93.7%
85.6%
MediosHI AMD***
90.62%
85.41%
*BMJ Open Diabetes Research and Care. 2020 Jan 1;8(1):e000892
